Ahmad Al Moujahed, MD
Ophthalmology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 16
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Massachusetts Eye and Ear Infirmary - · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
16 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Moujahed’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
16 of 16 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Massachusetts Eye and Ear Infirmary -Boston, MAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Mass General Brigham, which runs 15 hospitals in 2 statesPatients rate it 4 of 5 · 83% would definitely recommend itNo overall ratingWorse than the national rate — Postoperative hemorrhage or hematoma rate: 4.95 (3.56 to 6.33) · 544 cases, Jul 2022 – Jun 2024
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Massachusetts Eye and Ear Infirmary -
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative hemorrhage or hematoma rateComplications and deaths | 4.95 (3.56 to 6.33) · 544 cases | Worse | Jul 2022 – Jun 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.03 (0 to 2.11) · 100 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.83 (0.4 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 284 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 727 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.04 to 0.47) · 739 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.96 (0.53 to 5.39) · 581 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.55 (0 to 3.22) · 413 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.3 (0 to 16.28) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.79 (0.09 to 7.48) · 409 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 1.45) · 446 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.593 | No different | Oct 2024 – Sep 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.6 to 9.2) · 27 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 15.2) · 27 cases | No different | Jan 2024 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 692 cases | No different | Jan 2024 – Dec 2024 |
What patients said (351 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 92% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$36,708
Medicare paid this office $36,708 for 358 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Emergency department visit with low level of medical decision making | 149 | $8,574 | $56 |
| Emergency department visit with moderate level of medical decision making | 81 | $7,259 | $90 |
| Emergency department visit with high level of medical decision making | 29 | $4,081 | $141 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 20 | $2,990 | $149 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 12 | $1,770 | $147 |
See all 7 services
| Emergency department visit with low level of medical decision making | 149 | $8,574 | $56 |
| Emergency department visit with moderate level of medical decision making | 81 | $7,259 | $90 |
| Emergency department visit with high level of medical decision making | 29 | $4,081 | $141 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 20 | $2,990 | $149 |
| Removal of membrane of retina with removal of internal limiting membrane of retina | 12 | $1,770 | $147 |
| Short return visit (20+ min) | 13 | $658 | $51 |
| Imaging of retina | 18 | $376 | $20 |
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Who their Medicare patients are
358 Original Medicare patients in 2024. Average age 73 · Under 65 11% · 85 and older 8% · Women 55% · Also on Medicaid 24% · Health risk score 1.34. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 71% · Diabetes 28% · Coronary heart disease 28% · Depression 24% · Chronic kidney disease 23% · Atrial fibrillation 20% · Cancer 18% · Heart failure 15% · Stroke 15% · COPD 14% · Dementia 3%.
The office billed $237,028, Medicare allowed $47,772 and paid $36,708; for 415 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 358 | 415 | 73 | 1.34 | $237,028 | $36,708 |
| 2023 | 261 | 335 | 73 | 1.32 | $196,299 | $29,444 |
| 2022 | 97 | 135 | 72 | 1.15 | $69,415 | $11,047 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Emergency department visit with low level of medical decision making | 106 | $5,926 | $56 |
| Emergency department visit with high level of medical decision making | 25 | $3,684 | $147 |
| Emergency department visit with moderate level of medical decision making | 32 | $3,115 | $97 |
| Repair of detached retina with drainage and removal of eye fluid between lens and retina | 15 | $2,471 | $165 |
| Removal of eye fluid (vitreous) between lens and retina | 11 | $1,374 | $125 |
| Imaging of retina | 27 | $553 | $18 |
2022: 4 services
| Repair of detached retina with drainage and removal of eye fluid between lens and retina | 17 | $2,656 | $156 |
| Emergency department visit with low level of medical decision making | 39 | $2,357 | $60 |
| Emergency department visit with moderate level of medical decision making | 14 | $1,428 | $102 |
| Imaging of retina | 12 | $328 | $22 |
Medicaid work
$5,394 in 2024
Medicaid paid $5,394 for 151 billed services this clinician did in 2024, up to 25 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| EMERGENCY DEPT VISIT LOW MDM | 138 | $4,704 |
| EMERGENCY DEPT VISIT MOD MDM | 13 | $690 |
| 2024 | 151 | 2 | 25 | $5,394 |
| 2023 | 49 | 1 | 23 | $1,732 |
See the largest Medicaid services in earlier years
2023
| EMERGENCY DEPT VISIT LOW MDM | 49 | $1,732 |
Drugs they prescribed that Part D paid
$9,862
Pharmacies billed $9,862 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 317) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
200 generic and 117 brand-name prescriptions · $9,862 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prednisolone Acetate | 101 | $2,771 | $27 |
| Moxifloxacin | 89 | $1,628 | $18 |
| Atropine Sulfate | 40 | $824 | $21 |
| Dorzolamide-Timolol | 22 | $278 | $13 |
| Brimonidine | 19 | $136 | $7 |
See all 6 drugs
| Prednisolone Acetate | 101 | $2,771 | $27 |
| Moxifloxacin | 89 | $1,628 | $18 |
| Atropine Sulfate | 40 | $824 | $21 |
| Dorzolamide-Timolol | 22 | $278 | $13 |
| Brimonidine | 19 | $136 | $7 |
| Latanoprost | 11 | $60 | $5 |
Year by year
| 2024 | 317 | 120 | 0% (0) | 37% | $9,862 |
| 2023 | 514 | 184 | None | 33% | $21,228 |
| 2022 | 225 | 94 | None | 25% | $9,687 |
| 2019 | 54 | 31 | None | None | $1,842 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Prolensa | 16 | $5,921 | $370 |
| Prednisolone Acetate | 136 | $4,444 | $33 |
| Moxifloxacin | 88 | $2,680 | $30 |
| Atropine Sulfate | 54 | $1,416 | $26 |
| Dorzolamide-Timolol | 43 | $1,007 | $23 |
| Ketorolac Tromethamine | 50 | $824 | $16 |
| Erythromycin | 22 | $236 | $11 |
| Brimonidine | 31 | $234 | $8 |
2022: 5 drugs
| Prednisolone Acetate | 48 | $1,785 | $37 |
| Moxifloxacin | 28 | $959 | $34 |
| Atropine Sulfate | 27 | $840 | $31 |
| Erythromycin | 37 | $419 | $11 |
| Dorzolamide-Timolol | 12 | $310 | $26 |
Money from drug and device companies
$343 in 2023
| 2023 | 3 | 3 | None | $343 |
| 2022 | 1 | 10 | None | $336 |
| 2021 | 4 | 14 | None | $687 |
| 2020 | 1 | 1 | None | $123 |
| 2019 | 2 | 2 | None | $225 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Regeneron Pharmaceuticals | Eylea Hd | $141 | 1 payment
|
| Alcon Vision | Constellation | $134 | 1 payment
|
| Alimera Sciences | Iluvien | $68 | 1 payment
|
See all 3 published payments
| Alcon Vision | Meals · 2023-12-12 | Constellation | $134 |
| Regeneron Pharmaceuticals | Meals · 2023-11-17 | Eylea Hd | $141 |
| Alimera Sciences | Meals · 2023-02-21 | Iluvien | $68 |
See earlier years (2022, 2021, 2020, 2019)
2022: $336
| Alcon Vision | Acrysof Iq Panoptix Uv Iol | $336 | 10 payments
|
2021: $687
| Alcon Vision | Acrysof Iq Panoptix | $401 | 11 payments
|
| Carl Zeiss Meditec | Cirrus 5000 | $146 | 1 payment
|
| Genentech USA | None | $111 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Prolensa | $29 | 1 payment
|
2020: $123
| Regeneron Healthcare Solutions | Eylea | $123 | 1 payment
|
2019: $225
| Alimera Sciences | Iluvien | $125 | 1 payment
|
| Allergan | None | $100 | 1 payment
|
Professional record
- NPI
- 1073008777
- Licence
- MA 291384
- Group
- Stanford Health Care
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2018-06-25
- NPI last updated
- 2025-09-02
- NPI record certified
- 2025-09-02
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 243 Charles St, Boston, MA, 02114